IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals, Inc.

Q2 2026 Holdings

Filed 2026-08-07 | 3 holdings | $177.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Parabilis Medicines, Inc.(PBLS)Common Stock698955101$114.0M4,166,66664.4%
Intellia Therapeutics, Inc.(NTLA)Common Stock45826J105$62.7M3,702,99535.4%
Adicet Bio, Inc.(ACET)Common Stock007002207$522.8K60,5110.3%